Xin Guo

Anticancer activity of beta-L-dioxolane-cytidine, a novel nucleoside analogue with the unnatural L configuration.

K L Grove, Xin Guo, Shing‐Hwa Liu et al. · PubMed · 1995 · 142 citations

Cellular Deoxycytidine Kinase, Pharmacotherapy, Unnatural L Configuration +18

Resveratrol inhibits proliferation, migration and invasion of multiple myeloma cells via NEAT1-mediated Wnt/β-catenin signaling pathway

Weizheng Geng, Xin Guo, Lirong Zhang et al. · Biomedicine & Pharmacotherapy · 2018 · 97 citations

Tumor Biology, Cell Regulation, Chemoprevention Strategy +9

Identification and Characterization of Robust Hepatocellular Carcinoma Prognostic Subtypes Based on an Integrative Metabolite‐Protein Interaction Network

Di Chen, Yiran Zhang, Wen Wang et al. · Advanced Science · 2021 · 72 citations · Full text

Metabolic Pathways, Medicine, Hepatobiliary Tumor +13

The deubiquitinating enzyme UCHL1 promotes resistance to pemetrexed in non-small cell lung cancer by upregulating thymidylate synthase

Xinyuan Ding, Yuting Gu, Min Jin et al. · Theranostics · 2020 · 62 citations · Full text

BIBW 22, a dipyridamole analogue, acts as a bifunctional modulator on tumor cells by influencing both P-glycoprotein and nucleoside transport.

Hong Xing Chen, U. Bamberger, Armin Heckel et al. · PubMed · 1993 · 54 citations

Phenylpteridine Analogue, Molecular Biology, Tumor Cells +17